MiR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII

Cancer Letters

Volumn 337, Issue 1, 2013, Pages 115-124

  Chu, Ting Hui ^a   Yang, Cheng Chieh ^a,c   Liu, Chung Ji ^a,b   Lui, Mann Tin ^a,c   Lin, Shu Chun ^a,c   Chang, Kuo Wei ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

C Myc; Carcinoma; Head and neck; MiR 211; TGF RII; Transgenic mouse

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; MICRORNA; MICRORNA 211; MYC PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; EPITHELIUM TUMOR; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TONGUE CANCER; TRANSGENIC MOUSE; UPREGULATION;

C-MYC; CARCINOMA; HEAD AND NECK; MIR-211; TGFΒRII; TRANSGENIC MOUSE;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENES, MYC; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN;

MUS MUSCULUS;

EID: 84880041954     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.05.032     Document Type: Article

References (47)

1. Liu C.J., Tsai M.M., Hung P.S., Kao S.Y., Liu T.Y., Wu K.J., Chiou S.H., Lin S.C., Chang K.W. MiR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res. 2010, 70:1635-1644.
2. Chang K.W., Liu C.J., Chu T.H., Cheng H.W., Hung P.S., Hu W.Y., Lin S.C. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J. Dent. Res. 2008, 87:1063-1068.
3. Avissar M., McClean M.D., Kelsey K.T., Marsit C.J. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009, 30:2059-2063.
4. Hui A.B., Lenarduzzi M., Krushel T., Waldron L., Pintilie M., Shi W., Perez-Ordonez B., Jurisica I., O'Sullivan B., Waldron J., Gullane P., Cummings B., Liu F.F. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 2010, 16:1129-1139.
5. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11:9-22.
6. White R.A., Malkoski S.P., Wang X.J. TGFbeta signaling in head and neck squamous cell carcinoma. Oncogene 2010, 29:5437-5446.
7. Bian Y., Terse A., Du J., Hall B., Molinolo A., Zhang P., Chen W., Flanders K.C., Gutkind J.S., Wakefield L.M., Kulkarni A.B. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway. Cancer Res. 2009, 69:5918-5926.
8. Siegel P.M., Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 2003, 3:807-821.
9. Kwei K.A., Shain A.H., Bair R., Montgomery K., Karikari C.A., van de Rijn M., Hidalgo M., Maitra A., Bashyam M.D., Pollack J.R. SMURF1 amplification promotes invasiveness in pancreatic cancer. PloS one 2011, 6:e23924.
10. Lee D., Chung Y.H., Kim J.A., Lee Y.S., Jang M.K., Kim K.M., Lim Y.S., Lee H.C. Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma. Oncology 2012, 82:11-18.
11. Lin S., Yang J., Elkahloun A.G., Bandyopadhyay A., Wang L., Cornell J.E., Yeh I.T., Agyin J., Tomlinson G., Sun L.Z. Attenuation of TGF-beta signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells. Mol. Biol. Cell 2012, 23:1569-1581.
12. Liu Y.N., Abou-Kheir W., Yin J.J., Fang L., Hynes P., Casey O., Hu D., Wan Y., Seng V., Sheppard-Tillman H., Martin P., Kelly K. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor beta-initiated prostate cancer epithelial-mesenchymal transition. Mol. Cell Biol. 2012, 32:941-953.
13. Vergara D., Merlot B., Lucot J.P., Collinet P., Vinatier D., Fournier I., Salzet M. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 2010, 291:59-66.
14. Sakurai T., Kudo M. Signaling pathways governing tumor angiogenesis. Oncology 2011, 81(Suppl. 1):24-29.
15. Taylor M.A., Lee Y.H., Schiemann W.P. Role of TGF-beta and the tumor microenvironment during mammary tumorigenesis. Gene Exp. 2011, 15:117-132.
16. Lampropoulos P., Zizi-Sermpetzoglou A., Rizos S., Kostakis A., Nikiteas N., Papavassiliou A.G. TGF-beta signalling in colon carcinogenesis. Cancer Lett. 2012, 314:1-7.
17. Hoot K.E., Lighthall J., Han G., Lu S.L., Li A., Ju W., Kulesz-Martin M., Bottinger E., Wang X.J. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J. Clin. Invest. 2008, 118:2722-2732.
18. Lu S.L., Herrington H., Reh D., Weber S., Bornstein S., Wang D., Li A.G., Tang C.F., Siddiqui Y., Nord J., Andersen P., Corless C.L., Wang X.J. Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev. 2006, 20:1331-1342.
19. Liu C., Tang D.G. MicroRNA regulation of cancer stem cells. Cancer Res. 2011, 71:5950-5954.
20. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
21. Tu H.F., Lin S.C., Chang K.W. MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance. Curr. Opin. Otolaryngol. Head Neck Surg. 2013.
22. Janas M.M., Khaled M., Schubert S., Bernstein J.G., Golan D., Veguilla R.A., Fisher D.E., Shomron N., Levy C., Novina C.D. Feed-forward microprocessing and splicing activities at a microRNA-containing intron. PLoS Genet. 2011, 7:e1002330.
23. Mazar J., DeYoung K., Khaitan D., Meister E., Almodovar A., Goydos J., Ray A., Perera R.J. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PloS One 2010, 5:e13779.
24. Sakurai E., Maesawa C., Shibazaki M., Yasuhira S., Oikawa H., Sato M., Tsunoda K., Ishikawa Y., Watanabe A., Takahashi K., Akasaka T., Masuda T. Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells. Int. J. Oncol. 2011, 39:665-672.
25. Cai C., Ashktorab H., Pang X., Zhao Y., Sha W., Liu Y., Gu X. MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5. PloS One 2012, 7:e29750.
26. Geraldo M.V., Yamashita A.S., Kimura E.T. MicroRNA miR-146b-5p regulates signal transduction of TGF-beta by repressing SMAD4 in thyroid cancer. Oncogene 2012, 31:1910-1922.
27. Lo S.S., Hung P.S., Chen J.H., Tu H.F., Fang W.L., Chen C.Y., Chen W.T., Gong N.R., Wu C.W. Overexpression of miR-370 and downregulation of its novel target TGFbeta-RII contribute to the progression of gastric carcinoma. Oncogene 2012, 31:226-237.
28. Yu Y., Kanwar S.S., Patel B.B., Oh P.S., Nautiyal J., Sarkar F.H., Majumdar A.P. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFbetaR2) in colon cancer cells. Carcinogenesis 2012, 33:68-76.
29. Cheng P.L., Chang M.H., Chao C.H., Lee Y.H. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Oncogene 2004, 23:7821-7838.
30. Hsiao Y.C., Chang H.H., Tsai C.Y., Jong Y.J., Horng L.S., Lin S.F., Tsai T.F. Coat color-tagged green mouse with EGFP expressed from the RNA polymerase II promoter. Genesis 2004, 39:122-129.
31. Miyamoto S., Yasui Y., Kim M., Sugie S., Murakami A., Ishigamori-Suzuki R., Tanaka T. A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies. Carcinogenesis 2008, 29:418-426.
32. Pham N.A., Morrison A., Schwock J., Aviel-Ronen S., Iakovlev V., Tsao M.S., Ho J., Hedley D.W. Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn. Pathol. 2007, 2:8.
33. Biswas S., Chytil A., Washington K., Romero-Gallo J., Gorska A.E., Wirth P.S., Gautam S., Moses H.L., Grady W.M. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res. 2004, 64:4687-4692.
34. Li X., Placencio V., Iturregui J.M., Uwamariya C., Sharif-Afshar A.R., Koyama T., Hayward S.W., Bhowmick N.A. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene 2008, 27:7118-7130.
35. Yagi K., Furuhashi M., Aoki H., Goto D., Kuwano H., Sugamura K., Miyazono K., Kato M. C-myc is a downstream target of the Smad pathway. J. Biol. Chem. 2002, 277:854-861.
36. Dai M., Al-Odaini A.A., Arakelian A., Rabbani S.A., Ali S., Lebrun J.J. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFbeta-mediated breast cancer cell migration and invasion. Breast Cancer Res. 2012, 14:R127.
37. Fukai Y., Fukuchi M., Masuda N., Osawa H., Kato H., Nakajima T., Kuwano H. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int. J. Cancer 2003, 104:161-166.
38. Mincione G., Di Marcantonio M.C., Artese L., Vianale G., Piccirelli A., Piccirilli M., Perrotti V., Rubini C., Piattelli A., Muraro R. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas. Int. J. Oncol. 2008, 32:323-331.
39. Nerlich A.G., Sauer U., Ruoss I., Hagedorn H.G. High frequency of TGF-beta-receptor-II mutations in microdissected tissue samples from laryngeal squamous cell carcinomas. Lab Invest. 2003, 83:1241-1251.
40. Luscher B., Vervoorts J. Regulation of gene transcription by the oncoprotein MYC. Gene 2012, 494:145-160.
41. Bian Y., Hall B., Sun Z.J., Molinolo A., Chen W., Gutkind J.S., Waes C.V., Kulkarni A.B. Loss of TGF-beta signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 2011.
42. Bornstein S., White R., Malkoski S., Oka M., Han G., Cleaver T., Reh D., Andersen P., Gross N., Olson S., Deng C., Lu S.L., Wang X.J. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J. Clin. Invest. 2009, 119:3408-3419.
43. Ku T.K., Nguyen D.C., Karaman M., Gill P., Hacia J.G., Crowe D.L. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol. Cancer Res. 2007, 5:351-362.
44. Li J., Jiang T.X., Hughes M.W., Wu P., Widelitz R.B., Fan G., Chuong C.M. Progressive alopecia reveals decreasing stem cell activation probability during aging of mice with epidermal deletion of DNA methyltransferase 1. J. Invest. Dermatol. 2012, 132:2681-2690.
45. Tang X.H., Knudsen B., Bemis D., Tickoo S., Gudas L.J. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin. Cancer Res. 2004, 10:301-313.
46. Wilkey J.F., Buchberger G., Saucier K., Patel S.M., Eisenberg E., Nakagawa H., Michaylira C.Z., Rustgi A.K., Mallya S.M. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol. Carcinog. 2009, 48:853-861.
47. Pollari S., Leivonen S.K., Perala M., Fey V., Kakonen S.M., Kallioniemi O. Identification of microRNAs inhibiting TGF-beta-induced IL-11 production in bone metastatic breast cancer cells. PloS One 2012, 7:e37361.